Rabies vaccine - Berna BiotechAlternative Names: Lyssavac-HDC Berna
Latest Information Update: 15 Jun 2001
At a glance
- Originator Berna Biotech
- Class Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Rabies
Most Recent Events
- 15 Jun 2001 No-Development-Reported for Rabies in USA (IM)
- 15 Jun 2001 No-Development-Reported for Rabies in Thailand (IM)
- 27 Mar 1997 Investigation in Rabies in Thailand (IM)